MedTrace Logo

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-02-28

No results posted yet for this study

Summary

Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same approach had already been used and validated in lung tumors, leukemias and lymphomas. The main objective of the present research is to use tumor samples from patients in a retrospective and prospective cohort to test and validate the relevance of these prognostic markers in breast cancer.

Conditions

Interventions

OTHER

Conventional treatment protocols of breast cancer

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Anne-Cécile PHILIPPE, Dr · University Hospital, Grenoble

  • Mireille MOUSSEAU, Pr · Grenoble Alpes University Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2033-12-31
Completion
2033-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436069 on ClinicalTrials.gov